Gletvax 6

1 x 10 dose

Suspension for injection

Active substance

E. coli (K88ab) (F4ab) (attenuated)

E. coli (K88ac) (F4ac) (attenuated)

E. coli (K987P) (F6) (attenuated)

E. coli (K99) (F5) (attenuated)

ATC code

QI09AB08 Escherichia and Clostridium

QI09AB Inactivated bacterial vaccines (including Mycoplasma, Toxoid and Chlamydia)

QI09A Immunologicals for pig

QI09 Immunologicals for suidae

QI Immunologicals

Species

Pigs (sows and gilts).

Indications

A combined E. coli and Cl. perfringens Types B, C and D vaccine for pigs.

For the passive protection of piglets by the active immunisation of breeding sows and gilts to prevent neonatal colibacillosis caused by K99 bearing strains of E. coli; reduce neonatal colibacillosis caused by K88ab, K88ac and 987P bearing strains of E.coli and Cl. perfringens Type C necrotising infectious enteritis.

Dose to be administered and administration route

Dose: Sows and gilts 5 ml.

Administration: By subcutaneous injection, preferably behind the ear. The bottle should be well shaken before the vaccine is withdrawn.

Dosage schedule: The initial course consists of two doses:

Basic vaccination scheme: At service, or if necessary, at any time up to six weeks before farrowing.

Re-vaccination scheme: Two weeks before farrowing is expected.

Adverse reactions

In most pigs, a slight to moderate swelling (up to 6 cm) may be seen at the injection site after vaccination. The swelling will decline and disappear but may last from 14 to 21 days in some pigs.

Hypersensitivity reactions may occur very rarely. Prompt subcutaneous administration of adrenaline may relieve the condition.